de Vries B B, van den Ouweland A M, Mohkamsing S, Duivenvoorden H J, Mol E, Gelsema K, van Rijn M, Halley D J, Sandkuijl L A, Oostra B A, Tibben A, Niermeijer M F
Department of Clinical Genetics, University Hospital Dijkzigt and Erasmus University, Rotterdam, the Netherlands.
Am J Hum Genet. 1997 Sep;61(3):660-7. doi: 10.1086/515496.
The fragile X syndrome is an X-linked mental retardation disorder caused by an expanded CGG repeat in the first exon of the fragile X mental retardation (FMR1) gene. Its frequency, X-linked inheritance, and consequences for relatives all prompt for diagnosis of this disorder on a large scale in all affected individuals. A screening for the fragile X syndrome has been conducted in a representative sample of 3,352 individuals in schools and institutes for the mentally retarded in the southwestern Netherlands, by use of a brief physical examination and the DNA test. The attitudes and reactions of (non)consenting parents/guardians were studied by (pre- and posttest) questionnaires. A total of 2,189 individuals (65%) were eligible for testing, since they had no valid diagnosis, cerebral palsy, or a previous test for the FMR1 gene mutation. Seventy percent (1,531/2,189) of the parents/guardians consented to testing. Besides 32 previously diagnosed fragile X patients, 11 new patients (9 males and 2 females) were diagnosed. Scoring of physical features was effective in preselection, especially for males (sensitivity .91 and specificity .92). Major motives to participate in the screening were the wish to obtain a diagnosis (82%), the hereditary implications (80%), and the support of research into mental retardation (81%). Thirty-four percent of the parents/guardians will seek additional diagnostic workup after exclusion of the fragile X syndrome. The prevalence of the fragile X syndrome was estimated at 1/ 6,045 for males (95% confidence interval 1/9,981-1/ 3,851). On the basis of the actual number of diagnosed cases in the Netherlands, it is estimated that >50% of the fragile X cases are undiagnosed at present.
脆性X综合征是一种X连锁智力障碍疾病,由脆性X智力障碍(FMR1)基因第一个外显子中的CGG重复序列扩增引起。其发病率、X连锁遗传方式以及对亲属的影响,都促使对所有受影响个体进行大规模的该疾病诊断。在荷兰西南部的智障学校和机构中,对3352名个体的代表性样本进行了脆性X综合征筛查,采用了简单的体格检查和DNA检测。通过(测试前和测试后)问卷调查研究了(不)同意的父母/监护人的态度和反应。共有2189名个体(65%)符合检测条件,因为他们没有有效的诊断、脑瘫或之前未进行过FMR1基因突变检测。70%(1531/2189)的父母/监护人同意检测。除了32名先前诊断出的脆性X患者外,还诊断出11名新患者(9名男性和2名女性)。身体特征评分在预筛选中有效,但对于男性尤为有效(敏感性为0.91,特异性为0.92)。参与筛查的主要动机是希望获得诊断(82%)、遗传方面的考虑(80%)以及对智障研究的支持(81%)。34%的父母/监护人在排除脆性X综合征后将寻求进一步的诊断检查。估计男性脆性X综合征的患病率为1/6045(95%置信区间为1/9981 - 1/3851)。根据荷兰确诊病例的实际数量估计,目前超过50%的脆性X病例未被诊断出来。